Literature DB >> 34766627

Spatial dispersion analysis of LGE-CMR for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis.

Konstantinos N Aronis1,2, David R Okada1, Eric Xie1, Usama A Daimee1, Adityo Prakosa3,2, Nisha A Gilotra1, Katherine C Wu1, Natalia Trayanova3,2, Jonathan Chrispin1,2.   

Abstract

BACKGROUND: Patients with cardiac sarcoidosis (CS) are at increased risk of life-threatening ventricular arrhythmias (VA). Current approaches to risk stratification have limited predictive value.
OBJECTIVES: To assess the utility of spatial dispersion analysis of late gadolinium enhancement cardiac magnetic resonance (LGE-CMR), as a quantitative measure of myocardial tissue heterogeneity, in risk stratifying patients with CS for VA and death.
METHODS: Sixty two patients with CS underwent LGE-CMR. LGE images were segmented and dispersion maps of the left and right ventricles were generated as follows. Based on signal intensity (SI), each pixel was categorized as abnormal (SI ≥3SD above the mean), intermediate (SI 1-3 SD above the mean) or normal (SI <1SD above the mean); and each pixel was then assigned a value of 0 to 8 based on the number of adjacent pixels of a different category. Average dispersion score was calculated for each patient. The primary endpoint was VA during follow up. The composite of VA or death was assessed as a secondary endpoint.
RESULTS: During 4.7 ± 3.5 years of follow up, six patients had VA, and five without documented VA died. Average dispersion score was significantly higher in patients with VA versus those without (0.87 ± 0.08 vs. 0.71 ± 0.16; p = .002) and in patients with events versus those without (0.83 ± 0.08 vs. 0.70 ± 0.16; p = .003). Patients at higher tertiles of dispersion score had a higher incidence of VA (p = .03) and the composite of VA or death (p = .01).
CONCLUSIONS: Increased substrate heterogeneity, quantified by spatial dispersion analysis of LGE-CMR, may be helpful in risk-stratifying patients with CS for adverse events, including life-threatening arrhythmias.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  cardiac magnetic resonance imaging; cardiac sarcoidosis; late gadolinium enhancement; spatial dispersion; ventricular arrhythmia

Mesh:

Substances:

Year:  2021        PMID: 34766627      PMCID: PMC8688293          DOI: 10.1111/pace.14406

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  23 in total

1.  Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.

Authors:  Katherine C Wu; Gary Gerstenblith; Eliseo Guallar; Joseph E Marine; Darshan Dalal; Alan Cheng; Eduardo Marbán; João A C Lima; Gordon F Tomaselli; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2012-01-20       Impact factor: 7.792

2.  Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.

Authors:  Thomas Crawford; Gisela Mueller; Sinan Sarsam; Hutsaya Prasitdumrong; Naiyanet Chaiyen; Xiaokui Gu; Joseph Schuller; Jordana Kron; Khaled A Nour; Alan Cheng; Sang Yong Ji; Shawn Feinstein; Sanjaya Gupta; Karl Ilg; Mohamad Sinno; Saddam Abu-Hashish; Mouaz Al-Mallah; William H Sauer; Kenneth Ellenbogen; Fred Morady; Frank Bogun
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-09-29

Review 3.  Applications of Cardiac MR Imaging in Electrophysiology: Current Status and Future Needs.

Authors:  David R Okada; Katherine C Wu
Journal:  Magn Reson Imaging Clin N Am       Date:  2019-08       Impact factor: 2.266

4.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  Circulation       Date:  2018-09-25       Impact factor: 29.690

5.  Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.

Authors:  Riina Kandolin; Jukka Lehtonen; Juhani Airaksinen; Tapani Vihinen; Heikki Miettinen; Kari Ylitalo; Kari Kaikkonen; Suvi Tuohinen; Petri Haataja; Tuomas Kerola; Jorma Kokkonen; Markus Pelkonen; Päivi Pietilä-Effati; Seppo Utrianen; Markku Kupari
Journal:  Circulation       Date:  2014-12-19       Impact factor: 29.690

6.  Entropy as a Novel Measure of Myocardial Tissue Heterogeneity for Prediction of Ventricular Arrhythmias and Mortality in Post-Infarct Patients.

Authors:  Alexander F A Androulakis; Katja Zeppenfeld; Elisabeth H M Paiman; Sebastiaan R D Piers; Adrianus P Wijnmaalen; Hans-Marc J Siebelink; Marek Sramko; Hildo J Lamb; Rob J van der Geest; Marta de Riva; Qian Tao
Journal:  JACC Clin Electrophysiol       Date:  2019-02-27

Review 7.  Ventricular Arrhythmias in Cardiac Sarcoidosis.

Authors:  David R Okada; John Smith; Arsalan Derakhshan; Zain Gowani; Satish Misra; Ronald D Berger; Hugh Calkins; Harikrishna Tandri; Jonathan Chrispin
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

8.  Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.

Authors:  Hanna-Kaisa Nordenswan; Jukka Lehtonen; Kaj Ekström; Riina Kandolin; Piia Simonen; Mikko Mäyränpää; Tapani Vihinen; Heikki Miettinen; Kari Kaikkonen; Petri Haataja; Tuomas Kerola; Tuomas T Rissanen; Jorma Kokkonen; Aleksi Alatalo; Päivi Pietilä-Effati; Seppo Utriainen; Markku Kupari
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-08

9.  Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation.

Authors:  Hiroshi Ashikaga; Tetsuo Sasano; Jun Dong; M Muz Zviman; Robert Evers; Bruce Hopenfeld; Valeria Castro; Robert H Helm; Timm Dickfeld; Saman Nazarian; J Kevin Donahue; Ronald D Berger; Hugh Calkins; M Roselle Abraham; Eduardo Marbán; Albert C Lardo; Elliot R McVeigh; Henry R Halperin
Journal:  Circ Res       Date:  2007-10-04       Impact factor: 17.367

10.  Standard Ablation Versus Magnetic Resonance Imaging-Guided Ablation in the Treatment of Ventricular Tachycardia.

Authors:  Tarek Zghaib; Esra G Ipek; Rozann Hansford; Hiroshi Ashikaga; Ronald D Berger; Joseph E Marine; David D Spragg; Harikrishna Tandri; Stefan L Zimmerman; Henry Halperin; Scott Brancato; Hugh Calkins; Charles Henrikson; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-01
View more
  1 in total

Review 1.  Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death.

Authors:  Eric Xie; Eric Sung; Elie Saad; Natalia Trayanova; Katherine C Wu; Jonathan Chrispin
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.